🇺🇸 FDA
Patent

US 7687660

Process for preparing intermediates of HMG-CoA reductase inhibitors

granted A61PA61P3/06A61P43/00

Quick answer

US patent 7687660 (Process for preparing intermediates of HMG-CoA reductase inhibitors) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P3/06, A61P43/00